Opportunity Information: Apply for RFA DK 26 009
The New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed) is a National Institutes of Health (NIH) discretionary grant opportunity focused on strengthening the pipeline of new and early stage investigators working in type 1 diabetes (T1D) research. The program is built to fund innovative, preliminary-stage projects while also placing awardees inside the day-to-day intellectual environment of established, large-scale collaborative T1D research consortia. The core idea is that early career researchers do not just receive support for a small, targeted project; they also gain structured exposure to major ongoing collaborative efforts, which can accelerate their understanding of the field, improve access to expertise and resources, and help form career-shaping collaborations.
A defining feature of this opportunity is the "gateway" concept: applicants are expected to pursue their research within the scientific framework of select existing collaborative research programs rather than operating in isolation. By embedding new investigators into these networks, the NIH aims to create a two-way benefit. Awardees get mentorship, networking, and a clearer view of the key unanswered questions driving the T1D research agenda, while the consortia benefit from fresh perspectives, new ideas, and added capacity to explore emerging or high-risk directions that can later mature into larger studies. Because the funding mechanism is an R03, it is geared toward smaller, early-stage projects that can generate feasibility data, pilot results, or proof-of-concept findings that position investigators for larger follow-on grants.
This funding announcement explicitly indicates that clinical trials are not allowed under this R03. In practice, that means proposed work should be structured as non-clinical-trial research, such as preclinical studies, mechanistic investigations, analysis of existing data or biospecimens, exploratory translational studies that do not meet the definition of a clinical trial, or other preliminary research activities aligned with T1D priorities and suitable for an R03 scope. Applicants should design aims that are realistic for a small grant, emphasize innovation and potential impact, and clearly connect the project to the broader collaborative program environment where the work will be developed and refined.
The opportunity is listed under Funding Opportunity Number RFA DK 26 009 and falls under the grant funding instrument type, with activity areas noted as health and food and nutrition (CFDA number 93.847). The application deadline provided is March 6, 2026, and NIH anticipates making about 20 awards. The maximum award amount (ceiling) is $100,000, which signals that budgets and project plans should be tightly scoped and focused on achievable milestones that can be completed with limited resources.
Eligibility is broad and includes many domestic organization types, such as state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The announcement also highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions. At the same time, it clearly states that non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible, reinforcing that the applicant organization and the work supported must remain within allowable domestic boundaries.
Overall, this program is best read as a career-accelerating entry point into high-value collaborative T1D research: it supports small, innovative, early-stage projects and intentionally connects new investigators with established research networks so they can build relationships, learn the field's priorities, and produce the initial results needed to compete for larger grants later.Apply for RFA DK 26 009
- The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
- This funding opportunity was created on 2025-01-22.
- Applicants must submit their applications by 2026-03-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- The number of recipients for this funding is limited to 20 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQ)
What is the New Investigator Gateway Awards for Collaborative T1D Research?
It is an NIH discretionary grant opportunity designed to strengthen the pipeline of new and early stage investigators working in type 1 diabetes (T1D) research. It supports small, innovative, preliminary-stage projects while placing awardees within established, large-scale collaborative T1D research consortia.
What is the main goal of this program?
The program aims to accelerate early investigator development by combining funding for a tightly scoped R03 project with structured exposure to the intellectual environment, expertise, resources, and priorities of major ongoing collaborative T1D research efforts.
What does the "gateway" concept mean in this opportunity?
The "gateway" concept means applicants are expected to pursue their research within the scientific framework of select existing collaborative research programs, rather than operating in isolation. Awardees are embedded in these networks to gain mentorship and collaboration opportunities while contributing new ideas to the consortia.
What funding mechanism is used for this opportunity?
This opportunity uses the NIH R03 mechanism, which is intended for smaller, early-stage projects that can generate feasibility data, pilot results, or proof-of-concept findings.
Are clinical trials allowed under this funding announcement?
No. The funding announcement explicitly states "Clinical Trial Not Allowed" for this R03.
What kinds of research activities are appropriate given that clinical trials are not allowed?
Appropriate work includes non-clinical-trial research such as preclinical studies, mechanistic investigations, analysis of existing data or biospecimens, exploratory translational studies that do not meet the definition of a clinical trial, and other preliminary research activities aligned with T1D priorities that fit an R03 scope.
How should applicants think about project scope for an R03?
Applicants should design aims that are realistic for a small grant, emphasize innovation and potential impact, and focus on achievable milestones that can be completed with limited resources.
What is the Funding Opportunity Number (FOA) for this grant?
The Funding Opportunity Number is RFA DK 26 009.
What is the application deadline?
The application deadline provided is March 6, 2026.
How many awards does NIH expect to make?
NIH anticipates making about 20 awards.
What is the maximum award amount?
The maximum award amount (ceiling) is $100,000.
What does the $100,000 award ceiling imply for budgeting and planning?
It implies that budgets and project plans should be tightly scoped, focused on early-stage work, and built around milestones that can be completed with limited resources typical of an R03.
What type of funding instrument is this?
The opportunity is listed under the grant funding instrument type.
What activity areas are associated with this opportunity?
The activity areas noted are health and food and nutrition.
What is the CFDA number listed for this opportunity?
The CFDA number provided is 93.847.
Who is eligible to apply?
Eligibility is broad and includes many domestic organization types, including state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses.
Are minority-serving and mission-based organizations included in eligibility?
Yes. The announcement highlights additional eligible applicant categories including Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISI); Hispanic-serving institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); and faith-based or community-based organizations.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are listed among the additional eligible applicant categories.
Are federal agencies eligible to apply?
Yes. Eligible federal agencies are included among the additional eligible applicant categories.
Can foreign (non-U.S.) organizations apply?
No. The announcement clearly states that non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply.
Can a U.S. organization apply if the project includes a non-domestic component?
No. The opportunity states that non-domestic components of U.S. organizations are not eligible, reinforcing that the applicant organization and the work supported must remain within allowable domestic boundaries.
What is the program's intended benefit for early stage investigators?
The program is intended to provide both project support and structured exposure to established collaborative consortia, helping early investigators gain mentorship, build networks, access expertise and resources, and develop results that position them for larger follow-on grants.
How do the collaborative consortia benefit from these awards?
The consortia benefit from fresh perspectives, new ideas, and added capacity to explore emerging or higher-risk directions that may later mature into larger studies.
What kinds of outcomes is this R03 meant to produce?
It is meant to produce feasibility data, pilot results, or proof-of-concept findings that can support future, larger grant applications and longer-term research programs in T1D.
Is this opportunity primarily a research grant or a career development program?
Based on the description provided, it is a research grant (R03) that is explicitly designed as a career-accelerating entry point by embedding new investigators into collaborative T1D research networks.
Browse more opportunities from the same category: Food and Nutrition, Health
Next opportunity: Fiscal Year 2025 Tribal Homeland Security Grant Program
Previous opportunity: S/GWI FY24 NOFO: Women for Promoting Engagement, Accountability, Conflict Resolution and Empowerment (PEACE)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 26 009
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 26 009) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required) Apply for RFA DK 26 315 Funding Number: RFA DK 26 315 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 26 009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
